Wagner Amy W, Bystritsky Alexander, Russo Joan E, Craske Michelle G, Sherbourne Cathy D, Stein Murray B, Roy-Byrne Peter P
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine at Harborview Medical Center, Seattle, Washington 98104-2499, USA.
Depress Anxiety. 2005;21(3):99-105. doi: 10.1002/da.20067.
Primary health care clinics are increasingly providing psychiatric/psychological treatment of anxiety disorders, particularly for patients who do not have adequate access to specialty mental health services. Adequate treatment requires knowledge of and attention to patients' beliefs about available treatment options. The current investigation examined beliefs about psychotropic medications and psychotherapy among a sample of primary care patients with anxiety disorders. The influence of key demographic variables on strength of these beliefs was also explored. The presence of specific anxiety disorders was not found to impact strength of beliefs about either type of treatment. In contrast, there was a trend for the presence of depression to relate to more favorable attitudes toward psychotropic medication. Consistent with previous studies, ethnic minority patients reported less favorable attitudes toward both psychotropic medications and psychotherapy. These findings underscore the importance of assessing patient beliefs prior to the initiation of either psychotropic medications or psychotherapy across diagnostic and demographic groups. Practitioners should be particularly alert to the possibility that patients with anxiety disorders and members of ethnic minority groups may have less favorable attitudes toward treatment options. Treatment adherence may therefore be increased by addressing these beliefs directly.
基层医疗诊所越来越多地提供焦虑症的精神科/心理治疗，特别是对于那些无法充分获得专科心理健康服务的患者。充分的治疗需要了解并关注患者对现有治疗选择的看法。当前的调查研究了患有焦虑症的基层医疗患者样本对精神药物和心理治疗的看法。还探讨了关键人口统计学变量对这些看法强度的影响。未发现特定焦虑症的存在会影响对这两种治疗方式看法的强度。相比之下，存在抑郁症的患者对精神药物的态度往往更积极。与先前的研究一致，少数族裔患者对精神药物和心理治疗的态度都不太积极。这些发现强调了在开始对不同诊断和人口统计学群体进行精神药物治疗或心理治疗之前评估患者看法的重要性。从业者应特别警惕焦虑症患者和少数族裔群体成员对治疗选择的态度可能不太积极的可能性。因此，直接解决这些看法可能会提高治疗依从性。
